---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-017028"
form_type: "8-K"
ticker: "AGEN"
cik: "0001098972"
company_name: "AGENUS INC"
filed_at: "2025-02-10T23:59:59+00:00"
generated_at: "2026-05-26T23:47:26.817232+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Agenus receives termination notice from Incyte for LAG-3/TIM-3 license; rights revert to Agenus

## Summary
- Incyte terminates License Agreement effective Feb 4, 2026; all rights to LAG-3 and TIM-3 revert to Agenus.
- Incyte previously terminated OX40 (Oct 2023) and GITR/undisclosed (May 2024) programs.
- Agenus will evaluate future opportunities, including internal development or new partnerships.
- Termination follows Incyte's July 2024 announcement to discontinue LAG-3 and TIM-3 development.

## SEC filing metadata
- accession: 0000950170-25-017028
- form_type: 8-K
- ticker: AGEN
- cik: 0001098972
- company_name: AGENUS INC
- filed_at: 2025-02-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1098972/000095017025017028/0000950170-25-017028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1098972/000095017025017028/agen-20250204.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-017028
- JSON: https://secwatch.observer/filing/0000950170-25-017028.json
- Plain text: https://secwatch.observer/filing/0000950170-25-017028.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.